Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|18|9|830-846

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.9, 2018-11, pp. : 830-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer

By Zámečníkova Adriana  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 77-92

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoinformatic Approaches to Design Natural Product Type Ligands of ABC-Transporters

By  

Current Pharmaceutical Design, Vol. 16, Iss. 15, 2010-05 ,pp. : 1742-1752

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite

Fragment-Based Discovery of Inhibitors of Protein Kinase B

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 18, 2009-12 ,pp. : 1705-1717

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Bioactivities of Phenylamino-Pyrimidine Derivatives as Novel Protein Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 7, 2011-08 ,pp. : 596-601

Bentham Science Publishers

Access to resources Recommend Favorite